z-logo
open-access-imgOpen Access
SUN-340 Prolactinoma Response to Bevacizumab Is Influenced by Tumor Progression Stage at the Beginning of Treatment
Author(s) -
S Valla,
Gianina Demarchi,
Sofía Perrone,
Maria Parenti,
Silvia Berner,
Damasia Becú-Villalobos,
Carolina Cristina
Publication year - 2019
Publication title -
journal of the endocrine society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.046
H-Index - 20
ISSN - 2472-1972
DOI - 10.1210/js.2019-sun-340
Subject(s) - bevacizumab , prolactinoma , in vivo , medicine , saline , tumor progression , chemotherapy , stage (stratigraphy) , oncology , chemistry , prolactin , cancer , hormone , biology , paleontology , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here